---
title: "Regentis Biomaterials Ltd. (RGNT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGNT.US.md"
symbol: "RGNT.US"
name: "Regentis Biomaterials Ltd."
industry: "Biotechnology"
datetime: "2026-06-13T13:17:02.840Z"
locales:
  - [en](https://longbridge.com/en/quote/RGNT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGNT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGNT.US.md)
---

# Regentis Biomaterials Ltd. (RGNT.US)

## Company Overview

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.regentis.co.il](https://www.regentis.co.il) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.57 | 148 | - | - | - |
| PB | 1.64 | 164 | 3.47 | 3.28 | 2.24 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-03-02T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.50 |
| Highest Target | 10.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/RGNT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/RGNT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/RGNT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/RGNT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**